共 50 条
- [2] Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis [J]. Clinical Rheumatology, 2019, 38 : 63 - 70
- [5] Anti-tumor necrosis factor-alpha therapy for refractory uveitic optic disk neovascularization in active non-infectious posterior and panuveitis [J]. International Ophthalmology, 2021, 41 : 3523 - 3531